Effects of Olanzapine standard oral tablets and orally disintegrating tablets on gut hormones, glucose metabolism and pituitary hormones

Trial Profile

Effects of Olanzapine standard oral tablets and orally disintegrating tablets on gut hormones, glucose metabolism and pituitary hormones

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2010

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Psychotic disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Nov 2010 Status changed from active, no longer recruiting to completed, according to the ISRCTN record.
    • 20 Apr 2010 Results for the effects on insulin resistance and triglyceride levels published in the Journal of clinical psychiatry.
    • 01 Jun 2009 Results published in Psychoneuroendocrinology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top